Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
- PMID: 19763885
- DOI: 10.1007/s10689-009-9291-3
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
Abstract
Familial colorectal cancer (CRC) accounts for 10-15% of all CRCs. In about 5% of all cases, CRC is associated with a highly penetrant dominant inherited syndrome. The most common inherited form of non-polyposis CRC is the Lynch syndrome which is responsible for about 2-4% of all cases. Surveillance of individuals at high risk for CRC prevents the development of advanced CRC. About 1 million individuals in Western Europe are at risk for Lynch syndrome. We performed a survey to evaluate the strategies currently used to identify individuals at high risk for CRC in 14 Western European countries. Questionnaires were distributed amongst members of a European collaborative group of experts that aims to improve the prognosis of families with hereditary CRC. The survey showed that in all countries obtaining a family history followed by referral to clinical genetics centres of suspected cases was the main strategy to identify familial and hereditary CRC. In five out of seven countries with a (regional or national) CRC population screening program, attention was paid in the program to the detection of familial CRC. In only one country were special campaigns organized to increase the awareness of familial CRC among the general population. In almost all countries, the family history is assessed when a patient visits a general practitioner or hospital. However, the quality of family history taking was felt to be rather poor. Microsatellite instability testing (MSI) or immunohistochemical analysis (IHC) of CRC are usually recommended as tools to select high-risk patients for genetic testing and are performed in most countries in patients suspected of Lynch syndrome. In one country, IHC was recommended in all new cases of CRC. In most countries there are no specific programs on cancer genetics in the teaching curriculum for medical doctors. In conclusion, the outcome of this survey and the discussions within an European expert group may be used to improve the strategies to identify individuals at high risk of CRC. More attention should be given to increasing the awareness of the general population of hereditary CRC. Immunohistochemical analysis or MSI-analysis of all CRCs may be an effective tool for identifying all Lynch syndrome families. The cost-effectiveness of this approach should be further evaluated. All countries with a CRC population screening program should obtain a full family history as part of patient assessment.
Similar articles
-
Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.Rural Remote Health. 2011;11(4):1836. Epub 2011 Dec 22. Rural Remote Health. 2011. PMID: 22188021
-
The identification of Lynch syndrome in Congolese colorectal cancer patients.Bull Cancer. 2017 Oct;104(10):831-839. doi: 10.1016/j.bulcan.2017.08.005. Epub 2017 Oct 6. Bull Cancer. 2017. PMID: 28988047
-
Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.J Clin Oncol. 2015 Jan 10;33(2):209-17. doi: 10.1200/JCO.2014.58.1322. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452455 Free PMC article.
-
[Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].Zentralbl Chir. 2015 Dec;140(6):591-9. doi: 10.1055/s-0034-1368480. Epub 2014 Nov 5. Zentralbl Chir. 2015. PMID: 25372301 Review. German.
-
Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.World J Gastroenterol. 2015 Aug 21;21(31):9253-61. doi: 10.3748/wjg.v21.i31.9253. World J Gastroenterol. 2015. PMID: 26309352 Free PMC article. Review.
Cited by
-
Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway.Eur J Hum Genet. 2024 May;32(5):529-538. doi: 10.1038/s41431-024-01550-w. Epub 2024 Feb 15. Eur J Hum Genet. 2024. PMID: 38355963 Free PMC article.
-
Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statement.Hered Cancer Clin Pract. 2023 Oct 11;21(1):19. doi: 10.1186/s13053-023-00263-3. Hered Cancer Clin Pract. 2023. PMID: 37821984 Free PMC article. Review.
-
The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome.Front Oncol. 2023 Jul 19;13:1131011. doi: 10.3389/fonc.2023.1131011. eCollection 2023. Front Oncol. 2023. PMID: 37538120 Free PMC article.
-
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies.Front Oncol. 2023 Mar 22;13:1147590. doi: 10.3389/fonc.2023.1147590. eCollection 2023. Front Oncol. 2023. PMID: 37035178 Free PMC article. Review.
-
PMS2-associated Lynch syndrome: Past, present and future.Front Oncol. 2023 Feb 21;13:1127329. doi: 10.3389/fonc.2023.1127329. eCollection 2023. Front Oncol. 2023. PMID: 36895471 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical